Stoke Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell STOK and other ETFs, options, and stocks.

About STOK

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. 

CEO
Ian Frederick Smith
CEOIan Frederick Smith
Employees
170
Employees170
Headquarters
Bedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded
2014
Founded2014
Employees
170
Employees170

STOK Key Statistics

Market cap
1.61B
Market cap1.61B
Price-Earnings ratio
-7.42
Price-Earnings ratio-7.42
Dividend yield
—
Dividend yield—
Average volume
1.27M
Average volume1.27M
High today
$25.83
High today$25.83
Low today
$24.80
Low today$24.80
Open price
$25.53
Open price$25.53
Volume
1.63M
Volume1.63M
52 Week high
$40.22
52 Week high$40.22
52 Week low
$20.32
52 Week low$20.32

Stock Snapshot

The current Stoke Therapeutics(STOK) stock price is $25.04, with a market capitalization of 1.61B. The stock trades at a price-to-earnings (P/E) ratio of -7.42.

On 2026-10-24, Stoke Therapeutics(STOK) stock traded between a low of $24.80 and a high of $25.83. Shares are currently priced at $25.04, which is +1.0% above the low and -3.1% below the high.

Stoke Therapeutics(STOK) shares are trading with a volume of 1.63M, against a daily average of 1.27M.

In the last year, Stoke Therapeutics(STOK) shares hit a 52-week high of $40.22 and a 52-week low of $20.32.

In the last year, Stoke Therapeutics(STOK) shares hit a 52-week high of $40.22 and a 52-week low of $20.32.

STOK News

Simply Wall St 7d
What Stoke Therapeutics's ADOA Trial Update Means For Shareholders

Stoke Therapeutics recently shared new preclinical and early clinical data for its antisense drug STK-002 in Autosomal Dominant Optic Atrophy at the AAO 2026 me...

What Stoke Therapeutics's ADOA Trial Update Means For Shareholders

Analyst ratings

100%

of 14 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own STOK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.